Author:
Sze W C C,Grossman A B,Goddard I,Amendra D,Shieh S C C,Plowman P N,Drake W M,Akker S A,Druce M R
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Barakat MT, Meeran K, Bloom SR (2004) Neuroendocrine tumours. Endocr Relat Cancer 11: 1–18.
2. Basu B, Sirohi B, Corrie P (2010) Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin. Endocr Relat Cancer 17: R75–R90.
3. Bomanji JB, Papathanasiou ND (2012) (1)(1)(1)In-DTPA(0)-octreotide (Octreoscan), (1)(3)(1)I-MIBG and other agents for radionuclide therapy of NETs. Eur J Nucl Med Mol Imaging 39 (Suppl 1): S113–S125.
4. Castellani MR, Seghezzi S, Chiesa C, Aliberti GL, Maccauro M, Seregni E, Orunesu E, Luksch R, Bombardieri E (2010) (131)I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapy. Q J Nucl Med Mol Imaging 54: 100–113.
5. Department of Health MCSNi (2010) The National Cancer Survivorship Initiative Vision: Department of Health publications. www.dh.gov.uk/publications.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献